The personal experience of losing a child born with a rare disease and a brother with a chronic disease became the springboard for Dr. Harsha Rajasimha to apply his years of postdoctoral training at NIH and FDA to accelerating therapies for rare and common conditions. He knew that technology in itself is not the limiting factor and that patient-centered design guided by stakeholder needs and regulatory requirements would guide their continuous learning digital platform. By digitizing and automating manual repetitive tasks and reducing the logistical burdens on patients and study teams by over 70%, Jeeva accelerates the process of bringing new medicines or vaccines to patients who need them by over 3x faster. The Virginia-based company's modular software-as-a-service platform is fully scalable and facilitates patient enrollment, engagement, and evidence generation in clinical trials on any browser-enabled mobile device. Visit https://jeevatrials.com/

Next generation sequencing data analysis and interpretation Genomics and Transcriptomics Informatics for Molecular Diagnostics Cloud based Bioinformatics Services Consulting and contract R&D NGS data analysis and interpretation Genomics Transcriptomics and metagenomics Cloud based Bioinformatics LIMS Scientific advisory services Executive consulting BI and BigData Analysis Machine learning and AI Consulting and contract R&D Digital Patient Technologies Drug Discovery and Repurposing Biomarker research Systems Biology Biomedical Research Data driven Precision Medicine Research Data driven agricultural research Trait selection and plant breeding Marker assisted breeding precision medicine Consulting and contract R&D